Detail
LncRNA Name | DSCAM-AS1 |
Synonyms | DSCAM-AS1, M41 |
Region | GRCh38_21:40383083-40385358 Sequence |
Ensembl | ENSG00000235123 |
RefSeq | NR_038896 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | RNA-seq, qPCR, RNAi, ChIP, Cell proliferation assay etc. |
Sample | cell lines (MCF-7, HEK 293T, MDA-MB-231, SK-BR-3 etc.) |
Expression Pattern | up-regulated |
Function Description | The most abundant AER-lncRNA, DSCAM-AS1, is expressed in ERa+ breast carcinoma, but not in pre-neoplastic lesions, and correlates inversely with EMT markers. Down-regulation of DSCAM-AS1 recapitulated, in part, the effect of silencing ERa, i.e. growth arrest and induction of EMT markers. |
Pubmed ID | 26621851 |
Year | 2016 |
Title | Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer. |
External Links |
Links for DSCAM-AS1 | GenBank HGNC lncrnadb Noncode |
Links for breast cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.